How We Treat Drug-Susceptible Pulmonary Tuberculosis: A Practical Guide for Clinicians

Tuberculosis (TB) remains one of the leading causes of morbidity and mortality worldwide and pulmonary TB (PTB) is the main variant responsible for fueling transmission of the infection. Effective treatment of drug-susceptible (DS) TB is crucial to avoid the emergence of Mycobacterium tuberculosis-r...

Full description

Saved in:
Bibliographic Details
Published in:Antibiotics (Basel) Vol. 12; no. 12; p. 1733
Main Authors: Riccardi, Niccolò, Occhineri, Sara, Vanino, Elisa, Antonello, Roberta Maria, Pontarelli, Agostina, Saluzzo, Francesca, Masini, Tiziana, Besozzi, Giorgio, Tadolini, Marina, Codecasa, Luigi
Format: Journal Article
Language:English
Published: Switzerland MDPI AG 01.12.2023
Subjects:
BCG
BCG vaccines
Case reports
Chronic illnesses
Development and progression
Diabetes
diagnosis
Disease prevention
Disease transmission
Drug resistance
drug susceptible
Drug therapy
Epidemiology
Health aspects
Hemoptysis
HIV
Human immunodeficiency virus
India
Infections
Malnutrition
Medical imaging
Microscopy
Migration
Morbidity
Mortality
Pathogens
Patient compliance
Public health
pulmonary TB
Rifapentine
Risk factors
treatment
Tuberculosis
India
Pakistan
treatment
diagnosis
drug susceptible
pulmonary TB
tuberculosis
ISSN:2079-6382, 2079-6382
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Tuberculosis (TB) remains one of the leading causes of morbidity and mortality worldwide and pulmonary TB (PTB) is the main variant responsible for fueling transmission of the infection. Effective treatment of drug-susceptible (DS) TB is crucial to avoid the emergence of Mycobacterium tuberculosis-resistant strains. In this narrative review, through a fictional suggestive case of DS PTB, we guide the reader in a step-by-step commentary to provide an updated review of current evidence in the management of TB, from diagnosis to post-treatment follow-up. World Health Organization and Centre for Diseases Control (CDC) guidelines for TB, as well as the updated literature, were used to support this manuscript.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:2079-6382
2079-6382
DOI:10.3390/antibiotics12121733